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Dear  Editor,
Despite  much  research,  Continuous  Positive  Airway  Pres-
sure  (CPAP)  therapy  is  still  the  gold  standard  in  initial
treatment  for  central  sleep  apneas  syndromes  (CSAS)
related  to  congestive  heart  failure  (CHF).  Additionally,
adaptive  servoventilation  (ASV)  may  be  an  option  for
these  patients.1 CPAP  emergent  central  apnea  also  known
as  complex  sleep  apnea  syndrome  (CompSAS)  has  been
deﬁned  as  the  development  of  frequent  central  apneas  or
Cheyne--Stokes  respiratory  (CSR)  pattern  after  introduction
of  CPAP  therapy.2
We  read  with  great  interest  the  results  of  Correia  et  al.
and  consider  that  some  aspects  could  be  analyzed  for  proper
extrapolation  practice.3 The  present  study  approaches  an
important  subject  in  the  ﬁeld  of  sleep  disorder  breathing
(SDB).  Various  data  has  been  published  with  the  objective
of  deﬁning  which  treatment  is  most  appropriate  for  patients
with  SDB  and  CHF.  However,  some  comments  should  be  made
about  the  present  study.
First,  the  readers  need  a  more  precise  deﬁnition  when
the  diagnosis  was  made  in  CompSAS,  central  sleep  apnea
(CSA)  and  CSR.  In  this  context,  some  questions  need  to  be
posed,  was  the  diagnosis  made  during  the  baseline  sleep
study  and  was  the  baseline  sleep  study  also  a  split-night
sleep  study?  In  relation  to  patients  that  were  afterwards
treated  with  PAP,  should  not  the  second  sleep  study  include
CPAP/Auto-CPAP/BPAP  titration?
Second,  according  to  Javaheri  et  al.,  CompSAS  was  tran-
sitory  and  eliminated  after  8  weeks  of  CPAP  therapy.4 In  the
Abbreviations: ASV, adaptive servoventilation; CHF, conges-
tive heart failure; CompSAS, complex sleep apnea syndrome; CPAP,
Continuous Positive Airway Pressure; CSAS, central sleep apneas
syndromes; CSR, Cheyne--Stokes respiratory; LVEF, left ventricular
ejection fraction.
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ow  long  the  authors  waited  for  CompSAS  to  disappear  with
egular  CPAP  therapy,  before  performing  ASV  titration.
Third,  as  previously  stated  in  the  literature,  BPAP  in  the
pontaneous  mode  may  intensify  central  apnea  caused  by
yperventilation.1 in  relation  to  BPAP  patients,  the  authors
id  not  mention  if  S/T  mode  was  used  and  which  pressures
ere  necessary  for  optimal  treatment.
Fourth,  parameters  such  as  left  ventricular  ejection  frac-
ion  (LVEF)  and  treatment  compliance  have  been  used  to
ssess  ASV  vs.  CPAP  therapy  in  patients  with  both  CHF  and
DB.5 In  the  present  study  the  evaluation  of  LVEF  was  a  limi-
ation,  since  only  16  out  of  33  patients  had  a  cardiac  function
valuation  before  and  after  PSG  therapy  titration  and  deci-
ion.  An  interesting  fact  was  that  in  the  present  study  no
ifferences  were  encountered  in  terms  of  cardiovascular
CV)  mortality.
Future  studies  should  also  focus  on  long-term  effects  of
ersistent  CSA  in  asymptomatic  patients,  as  well  as  alter-
ative  pharmacological  interventions  for  patients  with  CSAS
nd  HF.
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eply to the letter to the editor
‘Sleep disorders breathing in
hronic heart failure. Is
daptive servoventilation really
he  answer?’’
ear  Dr.  Telma  Sequeira  and  Dr.  Antonio  M.  Esquinas,
e  thank  you  very  much  for  the  interesting  questions  about
ur  article.
In  the  group  of  patients  with  CSA/CSR  (40.6%  of  the  total
atients)  the  diagnosis  was  made  in  the  beginning,  with  a
olissonography.
In  the  group  with  CompSAS,  the  diagnosis  was  made  in
atients  who  presented  central  sleep  apnea  after  starting
reatment  with  autoCPAP/CPAP  for  obstructive  sleep  apnea.
hese  patients  maintained  a  high  AHI  despite  treatment
more  than  2--3  months  after  the  beginning  of  the  treat-
ent)  so  they  were  submitted  to  a  split-night  study  about  4
onths  after  the  initial  sleep  study.
All  the  patients  were  submitted  to  a  split  night  study  and
n  all  of  the  patients  the  technician  always  try  ﬁrst  the  treat-
ent  with  PAP  (CPAP/AutoCPAP/BIPAP)  but  because  it  did
ot  resolved  the  central  apnea,  the  technician  switched  to
ervoventilation,  with  excellent  results.1,2
Only  one  patient  was  treated  with  BIPAP  (S/T  mode).
he  ﬁrst  pressures  were  18/14  but  the  patient  suddenly
ied  and  we  had  no  time  to  optimize  the  best  pressures  for
im.
As  the  study  is  retrospective,  not  all  the  patients  had
reviously  realized  echocardiogram  before  PAP  therapy  so
The  authors  of  the  letter  say  that  in  the  present  study
no  differences  were  encountered  in  terms  of  cardiovascu-
lar  (CV)  mortality  but  this  is  not  what  we  demonstrated:
there  was  no  difference  in  terms  of  non-fatal  cardiovascular
events  (3  events  in  each  group)  but  in  PAP  group  2  patients
died  of  sudden  death.
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